Gain Therapeutics, Inc. (GANX)
1.79
-0.04
(-2.19%)
USD |
NASDAQ |
Sep 09, 14:06
Gain Therapeutics Total Assets (Quarterly) : 15.42M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 15.42M |
| March 31, 2026 | 18.74M |
| December 31, 2025 | 22.82M |
| September 30, 2025 | 10.97M |
| June 30, 2025 | 9.834M |
| March 31, 2025 | 11.62M |
| December 31, 2024 | 12.12M |
| September 30, 2024 | 14.37M |
| June 30, 2024 | 19.20M |
| March 31, 2024 | 14.58M |
| December 31, 2023 | 18.61M |
| September 30, 2023 | 14.10M |
| June 30, 2023 | 18.26M |
| March 31, 2023 | 21.32M |
| Date | Value |
|---|---|
| December 31, 2022 | 24.10M |
| September 30, 2022 | 28.33M |
| June 30, 2022 | 31.89M |
| March 31, 2022 | 37.60M |
| December 31, 2021 | 38.99M |
| September 30, 2021 | 42.56M |
| June 30, 2021 | 45.35M |
| March 31, 2021 | 48.04M |
| December 31, 2020 | 9.604M |
| September 30, 2020 | 9.623M |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 0.6603M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
| Vericel Corp. | 502.87M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 4.130M |
| Shareholders Equity (Quarterly) | 11.29M |
| Debt to Equity Ratio | 0.054 |
| Current Ratio | 4.359 |
| Net Debt Paydown Yield | 0.00% |